<DOC>
	<DOCNO>NCT00649064</DOCNO>
	<brief_summary>The purpose study see difference exist outcome patient schizophrenia schizoaffective disorder switch antipsychotic ziprasidone .</brief_summary>
	<brief_title>A Study Effects Ziprasidone Treatment Schizophrenia Schizoaffective Disorder Patients Who Were Switched From Other Antipsychotic Drugs</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder Outpatients least 3 month treatment sulpiride , olanzapine , quetiapine , risperidone least partial beneficial response typical antipsychotic treatment include current episode Partial improvement symptom justify switch ziprasidone Diagnosis major depression occurrence moderate depressive symptom Resistance conventional antipsychotic drug Treatment drug antiseizure medication , antipsychotic , antidepressant , mood stabilize agent might interfere assessement efficacy ziprasidone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>